Posted by Michael Wonder on 25 Aug 2019
Cannabis oil too expensive to prescribe to epileptic children on NHS, advisory body finds
23 August 2019 - A cannabis drug used to treat children with epilepsy is too expensive to prescribe even though it reduces patients’ seizures, the UK’s medical advisory body has said.
NICE announced today that it would not recommend cannabidiol combined with anti-seizure drug clobazam for the treatment of two types of severe epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.
Draft guidelines say that while there is evidence that cannabis oil reduces the number of seizures children have, the drug is too expensive and its long-term effects are unclear.
